Axalta Coating Systems Ltd. (AXTA) · Peers
Axalta Coating Systems against the 612 other companies here in its SEC industry, SIC 28xx (the wider group: its own four-digit code has fewer than five). Each figure is the one on the company's own page; the median is the peers', and the rank is among all 613, highest first.
Measure by measure
| Measure | AXTA | Peer median | Rank |
|---|---|---|---|
| Market value | $7.16B | median $255.06M | 79 of 603 |
| P/E | 19.4× | median 20.5× | 81 of 151 |
| Forward P/E | 12.7× | median 17.0× | 113 of 170 |
| EV/EBITDA | 9.6× | median 14.0× | 118 of 176 |
| P/S | 1.4× | median 4.5× | 416 of 546 |
| FCF yield | 6.8% | median -8.9% | 71 of 588 |
| Gross margin | 34.2% | median 55.2% | 251 of 363 |
| Operating margin | 13.8% | median -19.0% | 92 of 453 |
| Net margin | 7.2% | median -16.3% | 105 of 438 |
| ROIC | 11.2% | median -11.6% | 82 of 361 |
| ROE | 15.2% | median -28.1% | 82 of 488 |
| Revenue growth (4y, yearly) | 3.8% | median 2.3% | 216 of 465 |
| EPS growth (yearly) | 11.2% | median -0.8% | 21 of 84 |
| Net debt / EBITDA | 2.5× | median 2.3× | 51 of 109 |
| Current ratio | 2.1× | median 3.2× | 381 of 595 |
| Stock pay / revenue | 0.5% | median 7.2% | 438 of 529 |
| Share count change | -1.5% | median 6.5% | 513 of 566 |
Green where Axalta Coating Systems is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.
The peers, largest first
| Company | Market value | P/E | ROIC | Score |
|---|---|---|---|---|
| AXTAAxalta Coating Systems Ltd. | $7.16B | P/E 19.4× | 11.2% | 6.3 |
| LLYELI LILLY & Co | $1.18T | P/E 44.2× | 41.2% | 6.8 |
| JNJJohnson & Johnson | $615.87B | P/E 29.3× | 18.2% | 6.5 |
| ABBVAbbVie Inc. | $504.37B | P/E 79.9× | 25.6% | 5.7 |
| PGPROCTER & GAMBLE Co | $367.47B | P/E 22.9× | 21.2% | 6.2 |
| MRKMerck & Co., Inc. | $360.90B | P/E 113.7× | 6.2% | 5.3 |
| NVSNovartis AG ADR | $286.93B | P/E 20.5× | 21.2% | 7.4 |
| AZNAstraZeneca PLC | $256.54B | P/E 25.1× | 14.6% | 7.2 |
| AMGNAmgen Inc | $233.82B | P/E 26.7× | 14.9% | 6.3 |
| LINLinde plc Ordinary Shares | $231.25B | P/E 31.9× | 11.9% | 6.1 |
| GSKGSK plc | $213.73B | P/E 25.8× | 20.1% | 7.2 |
| GILDGilead Sciences Inc | $193.67B | P/E – | -5.3% | 5.1 |
| ABTAbbott Laboratories | $182.70B | P/E 29.1× | 9.8% | 6.3 |
| NVONovo Nordisk A/S | $171.70B | P/E 11.3× | 31.6% | 7.3 |
| PFEPfizer Inc | $167.74B | P/E 21.6× | – | 5.8 |
| ULUnilever PLC ADR | $144.33B | P/E 13.0× | 18.9% | 6.2 |
| VRTXVertex Pharmaceuticals Inc | $126.66B | P/E 28.8× | 30.2% | 7.3 |
| BMYBristol-Myers Squibb Company | $122.05B | P/E 13.1× | 17.1% | 7.9 |
| MRNAModerna, Inc. | $91.67B | P/E – | -116.5% | 2.8 |
| HLNHaleon plc | $90.72B | P/E 41.0× | 8.0% | 6.1 |
| REGNRegeneron Pharmaceuticals Inc | $83.82B | P/E 19.4× | 11.5% | 6.8 |
| ECLEcolab Inc | $79.99B | P/E 37.8× | 12.5% | 5.6 |
| CLColgate-Palmolive Company | $74.44B | P/E 36.5× | 32.1% | 6.0 |
| APDAir Products & Chemicals, Inc. | $66.71B | P/E – | -3.6% | 3.8 |
| ARGXargenx NV ADR | $50.69B | P/E 39.2× | 21.5% | 6.8 |
| SNYSanofi | $49.53B | P/E 5.7× | 6.0% | 6.9 |
| TEVATeva Pharma Industries Ltd ADR | $48.36B | P/E 68.5× | 14.8% | 6.3 |
| BNTXBioNTech SE | $44.22B | P/E – | -24.2% | 4.2 |
| IDXXIDEXX Laboratories Inc | $44.15B | P/E 38.7× | 57.2% | 6.8 |
| ONCBeOne Medicines Ltd. | $38.79B | P/E 59.2× | 69.3% | 7.6 |
| RVMDRevolution Medicines, Inc. | $38.14B | P/E – | – | 2.8 |
| ELEstee Lauder Companies Inc | $38.14B | P/E 209.5× | 8.7% | 4.5 |
| KVUEKenvue Inc. | $36.32B | P/E 21.9× | 11.6% | 6.1 |
| BIIBBiogen Inc | $34.35B | P/E 25.0× | 6.2% | 6.2 |
| RPRXRoyalty Pharma plc | $33.95B | P/E 41.7× | 6.5% | 6.9 |
| NTRNutrien Ltd. | $33.20B | P/E 14.5× | 8.1% | 6.2 |
| ZTSZoetis Inc. | $32.80B | P/E 12.5× | 27.8% | 7.1 |
| ALNYAlnylam Pharmaceuticals Inc | $31.02B | P/E 42.3× | – | 6.6 |
| CHDChurch & Dwight Company Inc | $24.72B | P/E 33.2× | 13.7% | 6.7 |
| PPGPPG Industries Inc | $23.83B | P/E 15.0× | 15.2% | 6.3 |
| IFFInternational Flavors & Fragrances Inc | $23.14B | P/E 82.6× | 3.3% | 5.2 |
And 572 smaller ones.
The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.